Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 111 Pages
Report ld: 6470680
Request Sample
Customized Report
The global Microfluidic Immunoassay System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Microfluidic Immunoassay System competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Microfluidic immunoassay systems are used for disease diagnostic, environmental monitoring, and food and drug screening.
The North American market for Microfluidic Immunoassay System is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Microfluidic Immunoassay System is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Microfluidic Immunoassay System include Abbott Laboratories, Quidel Corporation, Abaxis, Nanōmix, Koninklijke Philips, Biosurfit SA, Micropoint Bioscience, Siloam Biosciences, NanoEnTek, OPKO Health, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Microfluidic Immunoassay System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Microfluidic Immunoassay System. The Microfluidic Immunoassay System market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Microfluidic Immunoassay System market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Microfluidic Immunoassay System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Microfluidic Immunoassay System manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Microfluidic Immunoassay System sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Microfluidic Immunoassay System Market Overview
1.1 Product Definition
1.2 Microfluidic Immunoassay System by Type
1.2.1 Global Microfluidic Immunoassay System Market Value by Type: 2025 vs 2032
1.2.2 Microfluidic Analyzers
1.2.3 Microfluidic Cartridges
1.2.4 Other
1.3 Microfluidic Immunoassay System by Application
1.3.1 Global Microfluidic Immunoassay System Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Other
1.4 Global Microfluidic Immunoassay System Market Size Estimates and Forecasts
1.4.1 Global Microfluidic Immunoassay System Revenue 2021–2032
1.4.2 Global Microfluidic Immunoassay System Sales 2021–2032
1.4.3 Global Microfluidic Immunoassay System Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Microfluidic Immunoassay System Market Competition by Manufacturers
2.1 Global Microfluidic Immunoassay System Sales Market Share by Manufacturers (2021–2026)
2.2 Global Microfluidic Immunoassay System Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Microfluidic Immunoassay System Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Microfluidic Immunoassay System, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Microfluidic Immunoassay System, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Microfluidic Immunoassay System, Product Types and Applications
2.7 Global Key Manufacturers of Microfluidic Immunoassay System, Date of Entry into the Industry
2.8 Global Microfluidic Immunoassay System Market Competitive Situation and Trends
2.8.1 Global Microfluidic Immunoassay System Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Microfluidic Immunoassay System Players Market Share by Revenue
2.8.3 Global Microfluidic Immunoassay System Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Microfluidic Immunoassay System Market Scenario by Region
3.1 Global Microfluidic Immunoassay System Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Microfluidic Immunoassay System Sales by Region: 2021–2032
3.2.1 Global Microfluidic Immunoassay System Sales by Region: 2021–2026
3.2.2 Global Microfluidic Immunoassay System Sales by Region: 2027–2032
3.3 Global Microfluidic Immunoassay System Revenue by Region: 2021–2032
3.3.1 Global Microfluidic Immunoassay System Revenue by Region: 2021–2026
3.3.2 Global Microfluidic Immunoassay System Revenue by Region: 2027–2032
3.4 North America Microfluidic Immunoassay System Market Facts & Figures by Country
3.4.1 North America Microfluidic Immunoassay System Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Microfluidic Immunoassay System Sales by Country (2021–2032)
3.4.3 North America Microfluidic Immunoassay System Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Microfluidic Immunoassay System Market Facts & Figures by Country
3.5.1 Europe Microfluidic Immunoassay System Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Microfluidic Immunoassay System Sales by Country (2021–2032)
3.5.3 Europe Microfluidic Immunoassay System Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microfluidic Immunoassay System Market Facts & Figures by Region
3.6.1 Asia Pacific Microfluidic Immunoassay System Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Microfluidic Immunoassay System Sales by Region (2021–2032)
3.6.3 Asia Pacific Microfluidic Immunoassay System Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Microfluidic Immunoassay System Market Facts & Figures by Country
3.7.1 Latin America Microfluidic Immunoassay System Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Microfluidic Immunoassay System Sales by Country (2021–2032)
3.7.3 Latin America Microfluidic Immunoassay System Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microfluidic Immunoassay System Market Facts & Figures by Country
3.8.1 Middle East and Africa Microfluidic Immunoassay System Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Microfluidic Immunoassay System Sales by Country (2021–2032)
3.8.3 Middle East and Africa Microfluidic Immunoassay System Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Microfluidic Immunoassay System Sales by Type (2021–2032)
4.1.1 Global Microfluidic Immunoassay System Sales by Type (2021–2026)
4.1.2 Global Microfluidic Immunoassay System Sales by Type (2027–2032)
4.1.3 Global Microfluidic Immunoassay System Sales Market Share by Type (2021–2032)
4.2 Global Microfluidic Immunoassay System Revenue by Type (2021–2032)
4.2.1 Global Microfluidic Immunoassay System Revenue by Type (2021–2026)
4.2.2 Global Microfluidic Immunoassay System Revenue by Type (2027–2032)
4.2.3 Global Microfluidic Immunoassay System Revenue Market Share by Type (2021–2032)
4.3 Global Microfluidic Immunoassay System Price by Type (2021–2032)
5 Segment by Application
5.1 Global Microfluidic Immunoassay System Sales by Application (2021–2032)
5.1.1 Global Microfluidic Immunoassay System Sales by Application (2021–2026)
5.1.2 Global Microfluidic Immunoassay System Sales by Application (2027–2032)
5.1.3 Global Microfluidic Immunoassay System Sales Market Share by Application (2021–2032)
5.2 Global Microfluidic Immunoassay System Revenue by Application (2021–2032)
5.2.1 Global Microfluidic Immunoassay System Revenue by Application (2021–2026)
5.2.2 Global Microfluidic Immunoassay System Revenue by Application (2027–2032)
5.2.3 Global Microfluidic Immunoassay System Revenue Market Share by Application (2021–2032)
5.3 Global Microfluidic Immunoassay System Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Company Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Microfluidic Immunoassay System Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abbott Laboratories Microfluidic Immunoassay System Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Quidel Corporation
6.2.1 Quidel Corporation Company Information
6.2.2 Quidel Corporation Description and Business Overview
6.2.3 Quidel Corporation Microfluidic Immunoassay System Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Quidel Corporation Microfluidic Immunoassay System Product Portfolio
6.2.5 Quidel Corporation Recent Developments/Updates
6.3 Abaxis
6.3.1 Abaxis Company Information
6.3.2 Abaxis Description and Business Overview
6.3.3 Abaxis Microfluidic Immunoassay System Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abaxis Microfluidic Immunoassay System Product Portfolio
6.3.5 Abaxis Recent Developments/Updates
6.4 Nanōmix
6.4.1 Nanōmix Company Information
6.4.2 Nanōmix Description and Business Overview
6.4.3 Nanōmix Microfluidic Immunoassay System Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Nanōmix Microfluidic Immunoassay System Product Portfolio
6.4.5 Nanōmix Recent Developments/Updates
6.5 Koninklijke Philips
6.5.1 Koninklijke Philips Company Information
6.5.2 Koninklijke Philips Description and Business Overview
6.5.3 Koninklijke Philips Microfluidic Immunoassay System Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Koninklijke Philips Microfluidic Immunoassay System Product Portfolio
6.5.5 Koninklijke Philips Recent Developments/Updates
6.6 Biosurfit SA
6.6.1 Biosurfit SA Company Information
6.6.2 Biosurfit SA Description and Business Overview
6.6.3 Biosurfit SA Microfluidic Immunoassay System Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Biosurfit SA Microfluidic Immunoassay System Product Portfolio
6.6.5 Biosurfit SA Recent Developments/Updates
6.7 Micropoint Bioscience
6.7.1 Micropoint Bioscience Company Information
6.7.2 Micropoint Bioscience Description and Business Overview
6.7.3 Micropoint Bioscience Microfluidic Immunoassay System Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Micropoint Bioscience Microfluidic Immunoassay System Product Portfolio
6.7.5 Micropoint Bioscience Recent Developments/Updates
6.8 Siloam Biosciences
6.8.1 Siloam Biosciences Company Information
6.8.2 Siloam Biosciences Description and Business Overview
6.8.3 Siloam Biosciences Microfluidic Immunoassay System Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Siloam Biosciences Microfluidic Immunoassay System Product Portfolio
6.8.5 Siloam Biosciences Recent Developments/Updates
6.9 NanoEnTek
6.9.1 NanoEnTek Company Information
6.9.2 NanoEnTek Description and Business Overview
6.9.3 NanoEnTek Microfluidic Immunoassay System Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 NanoEnTek Microfluidic Immunoassay System Product Portfolio
6.9.5 NanoEnTek Recent Developments/Updates
6.10 OPKO Health
6.10.1 OPKO Health Company Information
6.10.2 OPKO Health Description and Business Overview
6.10.3 OPKO Health Microfluidic Immunoassay System Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 OPKO Health Microfluidic Immunoassay System Product Portfolio
6.10.5 OPKO Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microfluidic Immunoassay System Industry Chain Analysis
7.2 Microfluidic Immunoassay System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microfluidic Immunoassay System Production Mode & Process Analysis
7.4 Microfluidic Immunoassay System Sales and Marketing
7.4.1 Microfluidic Immunoassay System Sales Channels
7.4.2 Microfluidic Immunoassay System Distributors
7.5 Microfluidic Immunoassay System Customer Analysis
8 Microfluidic Immunoassay System Market Dynamics
8.1 Microfluidic Immunoassay System Industry Trends
8.2 Microfluidic Immunoassay System Market Drivers
8.3 Microfluidic Immunoassay System Market Challenges
8.4 Microfluidic Immunoassay System Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Microfluidic Immunoassay System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 127
USD 3950.00
(Single User License)
The global Microfluidic Immunoassay System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 77
USD 4250.00
(Single User License)
The global Microfluidic Immunoassay System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 141
USD 4900.00
(Single User License)
The global market for Microfluidic Immunoassay System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 102
USD 3950.00
(Single User License)
The global market for Microfluidic Immunoassay System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 85
USD 2900.00
(Single User License)
Microfluidic immunoassay systems are used for disease diagnostic, environmental monitoring, and food and drug screening.
Published Date: 2024-01-14
Pages: 95
USD 2900.00
(Single User License)
The global market for Microfluidic Immunoassay System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 127
The global Microfluidic Immunoassay System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 77
The global Microfluidic Immunoassay System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 141
The global market for Microfluidic Immunoassay System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 102
The global market for Microfluidic Immunoassay System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 85
Microfluidic immunoassay systems are used for disease diagnostic, environmental monitoring, and food and drug screening.
Published: 2024-01-14
Pages: 95
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now